Chordia Therapeutics Reports Large Exercise of Warrant Shares in April

TOKYO, Apr 20 (Pulse News Wire) – Chordia Therapeutics (190A.T) reported the large exercise of its ninth series of warrant shares (exercise price adjustment clause attached) from April 1 to April 20, 2026. During this period, 116,000 shares were delivered, with 2,000 warrants exercised on April 20 alone.

The total number of warrants exercised during the month was 1,230 out of the initial issuance of 1,340 warrants. As of April 20, there remain 110 unexercised warrants, down from 124 previously.

The exercise prices ranged from 5,000 to ¥200,000 per share.